1 lial cell apoptosis, Bcl-2/Bcl-X(L) chimeric
phosphorothioated 2'-MOE-modified antisense oligonucleot
2 ne's mRNA in human leukemia cells with fully
phosphorothioated 2'F-ANA-DNA chimeras (PS-2'FANA-DNA) a
3 es with lateral spacers strands comprised of
phosphorothioated adenine nucleotides (A15*).
4 Finally,
phosphorothioated analogs S-C5 and S-C6 were synthesized
5 Phosphorothioated antisense (AS) or sense oligonucleotid
6 With the use of a
phosphorothioated antisense oligodeoxynucleotide (ODN) t
7 pression of Abcc8, which encodes for SUR1 by
phosphorothioated antisense oligodeoxynucleotide essenti
8 Nuclease-resistant
phosphorothioated antisense oligonucleotides have been t
9 Conversely, depletion of Notch-1 with
phosphorothioated antisense oligonucleotides, correspond
10 transfection protocol with a 2-O-methylated
phosphorothioated antisense oligoribonucleotide (2OMeAO)
11 Phosphorothioated AS-ODN-c-myb was 30 times less potent
12 Phosphorothioated derivatives of antisense oligodeoxynuc
13 A
phosphorothioated DNA-RNA chimeric hammerhead ribozyme w
14 Phosphorothioated DNase I antisense oligodeoxynucleotide
15 Systemic administration of
phosphorothioated EGFR antisense oligonucleotides for 30
16 the uptake and distribution of an antisense
phosphorothioated oligodeoxynucleotide (s-ODN) to c-fos,
17 Using a fully
phosphorothioated oligodeoxynucleotide targeted to the f
18 Furthermore,
phosphorothioated oligodeoxynucleotides were found to an
19 An antisense
phosphorothioated oligonucleotide targeted to a unique s
20 s, and what was the effect of IL-6 antisense
phosphorothioated oligonucleotides.
21 confirmation rate during screening of fully
phosphorothioated (
PS)-LNA gapmer ASOs designed against
22 DNA recognition and cleavage by RAG1.RAG2 on
phosphorothioated substrates.
23 microbubble destruction-mediated delivery of
phosphorothioated TRAF3IP2 antisense oligonucleotides in